News Daily News Fish Oils: Yes for HF and Secondary Prevention, No for the General Population, Says AHA Michael O'Riordan March 15, 2017
News Daily News Statin-Intolerant Patients Have Significantly Worse Prognosis After MI Michael O'Riordan March 13, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Conference News ACC 2017 Erectile Dysfunction Meds Linked to Fewer Death and HF Hospitalizations After MI L.A. McKeown March 09, 2017
News Daily News Rising Subdural Hematoma Rates Appear to Be Linked to Greater Use of Antithrombotics Todd Neale March 03, 2017
News Conference News ISC 2017 Restarting Oral Anticoagulation After Intracerebral Hemorrhage Tied to Better Outcomes Todd Neale February 27, 2017
News Conference News ISC 2017 Early Statin Therapy Fails to Boost Acute Stroke Outcomes, but Trial Methods Questioned Todd Neale February 24, 2017
News Daily News ‘Misalignment’ Exists Between What Concerns Patients and Physicians Most After PCI Michael O'Riordan February 13, 2017
News Daily News Meta-analysis Adds Support to More Intensive Lowering of BP in Older Patients With Hypertension Todd Neale January 30, 2017
News Daily News Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy Michael O'Riordan January 18, 2017
News Daily News Younger Adults With Severe Dyslipidemia Less Likely to Be Prescribed Statins Michael O'Riordan January 05, 2017
News Conference News AHA 2016 Amid Rising Tide of Atherosclerotic CVD, Costs of Treatment Should Spur Policy Makers to Push Prevention Yael L. Maxwell November 29, 2016
News Conference News AHA 2016 Statin-Associated Muscle Pain? It May Be Your Genes, Says GAUSS-3 Analysis Michael O'Riordan November 22, 2016
News Industry News Two Differing Blood Clot Prevention Medications Used During Heart Procedure Are Both Safe and Effective for Patients, New Study Finds November 21, 2016
News Conference News AHA 2016 Proton Pump Inhibitor Use Tied to Elevated Ischemic Stroke Risk Todd Neale November 16, 2016
News Conference News AHA 2016 Racial Differences in How Patients Perceive CVD Risk Should Spur Rethink in Management Yael L. Maxwell November 16, 2016
News Conference News AHA 2016 Dabigatran Reversal Agent’s Safety, Efficacy Affirmed With Updated Study Results Todd Neale November 15, 2016
News Conference News AHA 2016 PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad Michael O'Riordan November 15, 2016
News Conference News AHA 2016 Declines in Cognition and Function Unaffected by Lowering BP, LDL Cholesterol in the Elderly: HOPE-3 Todd Neale November 13, 2016
News Conference News AHA 2016 No CV Safety Differences for COX-2 Inhibitor vs Other NSAIDs in PRECISION Shelley Wood November 13, 2016